Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy
A 47‐year‐old woman with mixed connective tissue disease was treated with abatacept. After 2 months, a 3‐cm depression with atrophied surface was observed on her back, which had histopathological consistent with the symptoms of localized scleroderma. Although some cases of paradoxical reaction or cu...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-06-01
|
| Series: | Journal of Cutaneous Immunology and Allergy |
| Online Access: | https://doi.org/10.1002/cia2.12215 |
| _version_ | 1797334423207673856 |
|---|---|
| author | Sayuko Nagaoka Shujiro Hayashi Ken Igawa |
| author_facet | Sayuko Nagaoka Shujiro Hayashi Ken Igawa |
| author_sort | Sayuko Nagaoka |
| collection | DOAJ |
| description | A 47‐year‐old woman with mixed connective tissue disease was treated with abatacept. After 2 months, a 3‐cm depression with atrophied surface was observed on her back, which had histopathological consistent with the symptoms of localized scleroderma. Although some cases of paradoxical reaction or cutaneous adverse event have been reported from abatacept, no localized scleroderma has been reported, suggesting this to be a unique case. |
| first_indexed | 2024-03-08T08:20:31Z |
| format | Article |
| id | doaj.art-9c9293a4d21a40b7bb3b96f886df684e |
| institution | Directory Open Access Journal |
| issn | 2574-4593 |
| language | English |
| last_indexed | 2024-03-08T08:20:31Z |
| publishDate | 2022-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Journal of Cutaneous Immunology and Allergy |
| spelling | doaj.art-9c9293a4d21a40b7bb3b96f886df684e2024-02-02T06:10:28ZengFrontiers Media S.A.Journal of Cutaneous Immunology and Allergy2574-45932022-06-0153949610.1002/cia2.12215Localized scleroderma secondary to mixed connective tissue disease during abatacept therapySayuko Nagaoka0Shujiro Hayashi1Ken Igawa2Department of Dermatology Dokkyo Medical University Mibu JapanDepartment of Dermatology Dokkyo Medical University Mibu JapanDepartment of Dermatology Dokkyo Medical University Mibu JapanA 47‐year‐old woman with mixed connective tissue disease was treated with abatacept. After 2 months, a 3‐cm depression with atrophied surface was observed on her back, which had histopathological consistent with the symptoms of localized scleroderma. Although some cases of paradoxical reaction or cutaneous adverse event have been reported from abatacept, no localized scleroderma has been reported, suggesting this to be a unique case.https://doi.org/10.1002/cia2.12215 |
| spellingShingle | Sayuko Nagaoka Shujiro Hayashi Ken Igawa Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy Journal of Cutaneous Immunology and Allergy |
| title | Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy |
| title_full | Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy |
| title_fullStr | Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy |
| title_full_unstemmed | Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy |
| title_short | Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy |
| title_sort | localized scleroderma secondary to mixed connective tissue disease during abatacept therapy |
| url | https://doi.org/10.1002/cia2.12215 |
| work_keys_str_mv | AT sayukonagaoka localizedsclerodermasecondarytomixedconnectivetissuediseaseduringabatacepttherapy AT shujirohayashi localizedsclerodermasecondarytomixedconnectivetissuediseaseduringabatacepttherapy AT kenigawa localizedsclerodermasecondarytomixedconnectivetissuediseaseduringabatacepttherapy |